A recent clinical trial sponsored by the National Institute of Allergy and Infectious Diseases shows promising 5-year evidence of sustained remission for people with multiple sclerosis (MS) who are treated with immunosuppressive therapy and an autologous stem cell transplant. For individuals with relapsing-remitting MS, the one-time treatment proved more effective than long-term use of MS drugs currently on the market. The news is encouraging for individuals with the often-debilitating disease, for whom traditional medications are ineffective. In this trial, 69 percent of the participants saw no new brain lesions or worsened neurological disability. Adverse effects of the treatment included infections and a reduction in blood cells due to the high dose of chemotherapy used.
At age 63, Dr. Shiva Vasishta is a neurologist with 38 years of experience, and according to reviews, his patients trust his decisions. Currently, Dr. Vasishta is affiliated with Eastern Neurodiagnostic Associates, a group practice in Voorhees, New Jersey. A graduate of Indira Gandhi Medical College, Dr. Shiva Vasishta did his fellowship in clinical neurophysiology at Tufts Medical Center, his neurology residency at Boston Medical Center and his residency for internal medicine at the Government Medical College and Hospital in Nagpur. Dr. Shiva Vasishta holds an American Board of Psychiatry and Neurology Certification in Neurology and he is Board Certified in Neurology.
Dr. Shiva Vasishta has expertise in treating MS as well as epilepsy, migraine disorders and Alzheimer’s disease. His hospital affiliations include the Medical Center at Princeton, Kennedy Memorial at Stratford-Cherry Hill and Virtua-Memorial Hospital of Burlington.